The broccoli constituent sulforaphane (l-isothiocyanate-4-methylsulfinylbutane) has previously been shown to protect rats against 9,10-dimethyl-l r 2-benz[a]anthracene tumorigenesis, thought to be due, at least in part, to induction of phase II detoxification. We investigated the ability of sulforaphane to also inhibit the phase I enzyme cytochrome P450 isoenzyme 2E1 (CYP2E1), which is responsible for activation of several carcinogens, including dialkylnitrosamines. Using the /7-nitrophenol hydroxylation assay in microsomes from livers of acetone-treated Sprague-Dawley rats, sulforaphane was shown to be a potent competitive inhibitor of CYP2E1 with a K x of 37.0 ± 4.5 uM. In view of this result, we studied the capacity of sulforaphane to inhibit the genotoxicity of /V-nitrosodimethylamine (NDMA). Sulforaphane at concentrations of >0.8 uM inhibited the mutagenicity of NDMA (4.4 mg/plate) in Salmonella typhimurium strain TA100 after pre-incubation for 45 min with cytosol extract from livers of Balb/c mice pre-treated with acetone. Unscheduled DNA synthesis induced by NDMA (33.5 (lM) in mouse hepatocytes was inhibited in a dose-dependent manner by sulforaphane at 0.064-20 uM. Sulforaphane was unable to inhibit mutagenicity of sodium azide (5 (ig/plate), a direct acting mutagen, in the Salmonella assay. It was not itself genotoxic in hepatocytes, as measured by unscheduled DNA synthesis, or mutagenic in the strain of Salmonella employed and cytotoxic only at high concentrations (5=03 mM). These findings suggest that inhibition of CYP2E1 by sulforaphane may offer chemoprotection against carcinogenic substrates of this enzyme.
Introduction
Epidemiological studies suggest that up to 10-70% of all human cancers in developed countries are associated with diet (1,2). Certain foods may contain a range of mutagens and/or carcinogens, such as aflatoxin B b nitrosamines, polycyclic aromatic hydrocarbons, hydrazines and heterocyclic amines (3) . However, the role of diet in cancer is not solely restricted
•Abbrevauons: DMBA, 9,10-dimethyl-l,2-benz[a|anthracene; PEITC, phenethyl isothiocyanate; NNK, 4-methylnitrosamino-l-(3-pyridyl)-l-butanone; CYP2E1, cytochrome P450 isoenzyme 2E1; NDMA, W-nitrosodimethylamine; DMEM, Dulbecco's modified Eagle's medium; HBSS, Hanks' baJanced salt solution; UDS, unscheduled DNA synthesis; NNG, net nuclear grain count.
to the delivery of carcinogens, since an increasing number of dietary factors have been characterized as possessing significant anti-mutagenic and anti-carcinogenic activities. Chemopreventors such as fibre, vitamins, flavonoids, isoflavones, polyphenols, carotenes, coumarins, aliphatic sulphides, aromatic isothiocyanates, indoles and selenium are currently under vigorous scrutiny as potential diet constituents (3) .
The mechanisms whereby chemopreventors exert their protective effect are not clear. Particular attention has been focused on 'intracellular' mechanisms (4) , including enhancement of enzymes involved in detoxification of carcinogens (phase II enzymes), inhibition of metabolic activation of carcinogens (phase I enzymes), trapping of electrophiles and free radicals and protection of nucleophilic sites in DNA. Feeding rodents with green coffee beans, cabbage, cauliflower and orange has been shown to reduce the risk of developing 9,10-dimethyl-l,2-benz[a]anthracene (DMBA*)-induced tumours (5) . Particular attention has been given to cruciferous vegetables, in particular those of the genus Brassica, in which sulforaphane [1-isothiocyanate-4-methylsulfinylbutane] (Figure 1 ) was identified as a potent inducer of phase II detoxification enzymes (6) . Sulforaphane at a dose of 15 |imol/mouse/day for 5 days induced mouse liver glutathione S-transferase ~2-fold and quinone reductase 2.5-fold (6) . Furthermore, recent research showed that sulforaphane blocks the formation of mammary tumours in Sprague-Dawley rats treated with DMBA, a carcinogen that is metabolically activated by cytochrome P450 isoenzyme 1A1 (7) . Related isothiocyanates have also been found to inhibit the tumorigenicity of nitrosamines in rodents. For example, phenethyl isothiocyanate (PEITC) inhibited the tumorigenesis of 4-methylnitrosamino-l-(3-pyridyl)-l-butanone (NNK) in rat lung (8) and of N-nitrosomethylbenzylamine in rat oesophagus (9) . Benzylisothiocyanate inhibited Nnitrosodiethylamine-induced neoplasms in the forestomach of A/J mice (10) . It is conceivable that sulforaphane mediates chemoprotection via more than one mechanism and its effect on phase I enzymes involved in the activation of carcinogens has so far been given scarce attention. It is not known if sulforaphane is able to inhibit cytochrome P450 isoenzymes, although it appears to be a monofunctional inducer of phase II enzymes and unlikely to be an inducer of CYP1A1 (6) . Because related isothiocyanates particularly inhibit cytochrome P450 isoenzyme 2E1 (CYP2E1) (11) and inhibit the tumorigenesis of certain CYP2E1 substrates (see above), we have investigated the effect of sulforaphane on CYP2E1, which is abundantly expressed in human liver and responsible for the metabolic activation of a range of genotoxic chemicals, including JV-nitrosodimethylamine (NDMA) (12) . The influence of sulforaphane on the genotoxicity in vitro of the CYP2E1 substrate /V-nitrosodimethylamine (13) was also assessed in two test systems. 
Materials and methods

Chemicals
Synthesis of sulforaphane
Sulforaphane was synthesized by the method of Schmid and Karrer (14) with various modifications. Sulforaphane was synthesized essentially via 1-methylsulfinylphthalimidobutane, prepared from bromobutanephthalimide and CHsSNa. The sulphide moiety was oxidized with m-chloroperoxybenzoic acid. Deprotective removal of phthalimide using hydrazine hydrate yielded the amine O^SCKC^^Nfy, which was converted into sulforaphane by reaction with A^'-thionocarbonyldiimidazole. Purity (95%) was checked by 'H-NMR, 13 C-NMR and infrared and mass spectrometry.
Animals
Initial studies on the inhibition of CYP2E1 used rat liver microsomes. Subsequent studies on genetic toxicity employed mouse liver preparations, since this species would be used for subsequent in vivo studies in order to limit the amount of sulforaphane required. Male Sprague-Dawley rats, 100-200 g, were purchased from Bantin and Kingman Ltd (Hull, UK) and fed Heygate Rat and Mouse Breeding Diet and water ab libitum unless stated otherwise. Male Balb/c mice (-20 g; Harlan UK Ltd) received Rat and Mouse Maintenance Diet (Special Diet Service, UK) and water ab libitum unless stated otherwise.
Assay of CYP2E1
Enzyme activity was assessed spectrophotometrically by measurement of the hydroxylation of p-nitrophenol to p-nitrocatechol essentially as described before (15) .
Control and treated (1% acetone in drinking water for 2 weeks) rat liver microsomes were obtained by differential centrifugation (16) to give a suspension equivalent to 0.5 g original liver wet wt/ml buffer. Acetone pretreatment induced CYP2E1 activity (p-nitrophenol oxidation) by 100%, as reported els where (16) .
All incubations were carried out, with duplicate samples, in 2 ml Eppendorf tubes with shaking at 37°C. Incubations contained 200 pJ of either control or induced rat liver microsoma] preparations, 100 |il 1 mM NADPH, 100 uJ 10 mM ascorbic acid, 400-500 uJ phosphate buffer, pH 6.8, 100 uJ 50-500 \iM />-nitrophenol and (when required) the inhibitors (dissolved in distilled water) sulforaphane (100 \i\, 25-250 uM) or PEITC (100 uJ, 10-100 uM). The reaction was terminated after 30 rnin by addition of 0.5 ml 0.7 M HC1O 4 . In a preliminary study linearity of generation of 4-nitrocatechol with time during the incubation period was established. The inhibition constant K, (mean ± SD, n = 3) was calculated from Dixon plots (1/v versus concentration of inhibitor) (n = 3, all samples in duplicate).
Genetic toxicity assays
Male Balb/c mice were used for the preparation of liver 9000 g supematants (S9) and hepatocytes. Acetone (1%) was administered in drinking water for 7 days to induce CYP2E1. This was induced in mice by 130%, as reported elsewhere (16) .
Bacterial mulagenicity assay
Mutagenicity was assessed in the Salmonella typhimurium pre-incubation reverse gene mutation assay according to Maron and Ames (17) . The S.typhimurium strain TA100 was kindly provided by B.N.Ames (University of California, CA). The spontaneous reversion rate ranged from 71-195 colonies/plate to 158-176 colonies with control S9 to 93-193 colonies with acetone-induced S9. The test compounds (sulforaphane, 2-aminofluorene and sodium azide) were dissolved in distilled water. Liver S9 (10%) was prepared from control and acetone-induced mouse livers by homogenization and centrifugation at 9000 g for 10 min. All analyses were carried out in triplicate, unless stated otherwise. Sulforaphane was tested for mutagenicity with and without metabolic activation at eight different concentrations ranging from 0.032 to 2500 | XM, with acetone-induced S9 at three concentrations (20, 100 and 200 uM).
For the inhibition studies the mutagens NaN 3 and NDMA (dissolved in distilled water) were each tested at one concentration, 5 pg/plate and 4.4 mg/ plate respectively. Sulforaphane was studied at seven concentrations (0.032-100 nM). NaN 3 was analysed without metabolic activation. For studies of inhibition of NDMA mutagenicity the components, bacteria and acetoneinduced liver S9 (10%) were pre-incubated for 45 min prior to plating. Samples which showed at least twice the background number of revertants were considered mutagenic and dose-response relationships were assessed as detailed below.
DNA repair assay
Hepatocytes were isolated from untreated mouse livers by the collagenase perfusion method of Berry and Friend (18) with the following modifications. Mice were anaesthetized with a mixture of Hypnorm:Hypnovel:water (1:1:2) (1 ml/100 g, i.p. injection) and, after drowsiness was observed, sodium pentobarbitone (1 ml/kg body wt) was given by i.p. injection. The liver was pre-perfused at 37°C with -50 ml of Ca 2+ -free HBSS, pH 7.4 (10% HBSS, 5% HEPES, 4 mM NaHCO 3 ), followed by perfusion with collagenase solution (60 ml Ca 2+ -frce HBSS, 45 mg collagenase A, 40 mg Ca 2 Cl). The perfusion was carried out at a flow rate of 6-7 ml/min. Cell viability was determined by the trypan blue exclusion method (19) and was always >75%. The average yield of hepatocytes was of 2.5 X 10 7 cells/liver with an average viability of 80%.
The DNA repair assay was based on that of Sandhu et al. (20) for the measurement of nuclear incorporation of [ A cell in repair was defined as exhibiting a net nuclear grain count (NNG) > 0 (21) and results and dose-response effects were evaluated according to international guidelines (21, 22) .
Statistical analyses
Genotoxicity tests were analysed by the statistical method of Dunnett (23), except for inhibition of NDMA-mediated mutagenicity by sulforaphane in Salmonella typhimurium strain TA100, which was assessed by analysis of variance (ANOVA), and inhibition of DNA repair by sulforaphane, analysed by linear regression.
Results
Inhibition ofCYP2E1
p-Nitrophenol hydroxylase activity in liver microsomes from acetone-induced rats was measured to reflect activity of CYP2E1. Microsomal p-nitrophenol hydroxylation was characterized by a K m of 69.52 ± 7.92 |iM and a V m of 0.53 ± 0.02 nmol/mg/min for control microsomes and a K m of 119.24 ± 7.61 (iM and a V m of 1.96 ± 0.05 nml/mg/min for acetoneinduced microsomes. Using this assay sulforaphane was found to be a potent competitive inhibitor of enzyme activity ( Figure  2 ). The inhibition constant K t , calculated from Dixon plots (Figure 2 ), was 37.0 ± 4.5 ^M (mean ± SD, n = 3). For comparison, the sulforaphane congener PEITC was also investigated and yielded a K-t of 13.1 ± 1.1 (iM.
Genotoxic potential of sulforaphane
The mutagenic potency of sulforaphane was assessed in S.typhimurium strain TA100 at eight different concentrations (Table I) . Sulforaphane at 0.5 and 2.5 raM was cytotoxic in all experiments, as evidenced by a decrease in the background lawn of auxotrophs. Sulforaphane (0.032-100 [iM) was found to lack mutagenic potential with or without S9. Mutagenicity of sulforaphane was also tested with S9 from acetone-treated animals. Three concentrations were tested (20, 100 and 200 (iM) and proved non-mutagenic (data not shown).
Sulforaphane was studied at five different concentrations (0.032, 0.16, 0.8, 4 and 20 \iM) for its ability to induce UDS in mouse hepatocytes. The concentrations chosen were all below that required for cytotoxicity. Sulforaphane at 40 p.M was cytotoxic, causing 33% loss of cell viability as indicated by lactate dehydrogenase release. The cytoplasmic grain count, which ranged from 14.9 to 21.9 (n = 21), and the percentage of hepatocytes in S phase (-0.1%) were similar throughout all experiments. In control incubations 33.5 |i.M NDMA significantly induced UDS. All concentrations of sulforaphane gave a negative response (Table II) .
Inhibition of NDMA genotoxicity by sulforaphane
The ability of sulforaphane to inhibit genotoxicity of NDMA was assessed in S.typhimurium strain TA100 and in the UDS assay. NDMA is activated by CYP2E1 to a genotoxic product and causes base pair substitutions in S.typhimurium strain TA100. In order to maximize its response in these bacteria, S9 from acetone-induced livers was used and the pre-incubation time was prolonged from 20 to 45 min. On co-incubation with NDMA sulforaphane reduced the frequency of revertants compared with the positive control ( There was a clear dose-response effect and a significant linear trend with dose (analyzed by ANOVA, P < 0.001).
The influence of sulforaphane on the induction of UDS by NDMA in mouse hepatocytes is shown in Figure 3 . The cytoplasmic grain count (13.4 ± 2.5, n = 66) did not differ significantly throughout the experiments. Also, no difference was observed in the number of cells in S phase (-0.1%) between the control and treatment groups. The presence of sulforaphane during treatment with NDMA reduced NNG markedly compared with the positive control, which contained NDMA alone. Inhibition of NDMA-induced UDS by sulforaphane was clearly dose-dependent for all concentrations tested (linear regression, P < 0.001). NNG values varied from 10.3 ± 2.2 for 6.4 nM sulforaphane to 1.4 ± 0.5 for 20 \iM sulforaphane. The positive and negative controls were 17.6 ± 0.5 and -5.0 ± 0.9 respectively.
Influence of sulforaphane on sodium azide mutagenicity
Sulforaphane did not affect the mutagenicity of NaN 3 at either 5 or 1.7 ng/plate in S.typhimurium strain TA 100. The number of his + revertants per plate (n = 2) was similar for control (5 (ig/plate NaN 3 , 1367 revertants) compared with 5 u.g/plate NaN 3 plus sulforaphane 100 |J.M (1164 revertants) and there was no dose-dependent response (0.03-100 \lM sulforaphane). Test compounds, mouse liver S9 (where appropriate) and bacteria were pre-incubated for 20 min prior to pouring onto agar plates. NaN 3 (1 ug/plate) was used as a positive control for incubations without metabolic activation and gave 1856 ±119 and 517 ± 4 revertants/plate for experiments 1 and 2 respectively. 2-Aminofluorene (10 |ig/plate) was the positive control for incubations containing mouse liver S9 and gave 1923 ± 89 and 1815 ± 97 revelants/ plate for experiments 3 and 4 respectively. All values were not statistically different from controls (analysed by Dunnett's method; 23).
"All values are expressed as the mean of the number of His + revertants/plate ± SD (n = 3), including spontaneous revertants.
Discussion
Naturally occurring isothiocyanates of cruciferous origin have been shown to inhibit carcinogenesis by dialkylnitrosamines and polycyclic aromatic hydrocarbons (3) (4) (5) (7) (8) (9) (10) . In a study of the chemoprotective effect of sulforaphane Zhang et al. (6, 7) showed the relatively high potency of this isothiocyanate as an inducer of phase II enzymes. In their concluding remarks the authors pointed to the fact that little is known about the ability, if any, of sulforaphane to inhibit the metabolic activation of carcinogens. It has been reported that a number of other isothiocyanates inhibit cytochrome P450-mediated activation of nitrosamines to DNA-reactive products, for example NNK (24) or A'-nitrosomethylbenzylamine (9). Isothiocyanate molecules which bear lipophilic groups seem to be particularly able to inhibit cytochrome P450 (25) and to exert antitumorigenicity towards NNK (26) .
In the results outlined above the hypothesis was tested that sulforaphane can protect against the genotoxic activity of carcinogens by reduction of metabolic activation and the study was especially focused on CYP2E1-mediated activation of NDMA. Sulforaphane was a strong competitive inhibitor of CYP2E1, albeit slightly less potent than its congener PEITC, which has previously been shown to inhibit NDMA demethylase activity (11), as well as tumorigenesis of NNK in rat lung (8) and A'-nitrosomethylbenzylamine in rat esophagus (9) . A ]thymidine were incubated with mouse hepatocytes for 20 h. NNG was determined by autoradiography. The positive control, 33.5 |iM NDMA, gave a NNG of 9.5 ± 2.9 and 32.3 ± 13.7 for experiments 1 and 2 respectively.
•For each experiment values given are the mean ± SD, n -3 slides. Nuclear and cytoplasmic grains were counted in 50 cells/slide.
non-competitive component as reported for the inhibition of cytochrome P450 enzymes by other isothiocyanates (24,25) was not detected.
We then investigated whether sulforaphane inhibits the genotoxicity of NDMA in both bacterial and mammalian systems, since this toxicant is mainly activated by CYP2E1 (27) . Sulforaphane itself was not mutagenic in S.typhimurium strain TA100, which is sensitive to base pair substitutions (16) , nor did it induce UDS in mouse hepatocytes at concentrations of up to 20 H.M (40 uM was cytotoxic). This finding supports the notion that the chemopreventive effect of sulforaphane is not marred by inherent genotoxicity, although this conclusion should be confirmed in other assays. The lack of genotoxicity contrasts with the effect of the sulforaphane analog allyl isothiocyanate, which is mutagenic in S.typhimurium strain ]thymidine for 20 h. NNG was determined by autoradiography and 50 cells were counted manually for every slide. Values are the mean ± SD (n = 3) and all doses were analysed in triplicate. All doses were significantly lower than with the posiuve control NDMA alone (P < O.Ol by Dunnett's method) and linear regression was significant (P < 0.001). *n = 2; "distilled water was used for the blank. Sulforaphane, NDMA (4.4 mg/plate), acetone-induced S9 and bacteria were pre-incubated for 45 min before the mixture was poured onto the agar plates. Colonies were counted after 48 h. Because of variation in the absolute response to NDMA in each experiment, the inhibitory effect of sulforaphane is shown for each. "Number of His" 1 " revertants per plate including background spontaneous rate, mean ± SD (n = 3; except c n = 2). Spontaneous revertants were 186.7 ± 33.3, 191.0 ± 2.7, 187.0 ± 18.5 and 94.7 ± 1.5 respectively for experiments 1-4. Statistics analyzed by ANOVA, significant linear trend with dose for every experiment, P < 0.01. ''Per cent inhibition was calculated following subtraction of the spontaneous revertants. Values are significantly different from controls at 0.8 nM sulforaphane (P < 0.05) and above (P < 0.01), Student's Mest. TA100 (28) , and with the clastogenicity of a range of other isothiocyanates (29) .
Sulforaphane-mediated inhibition of the genotoxicity of NDMA showed marked dose dependency in both S.typhimurium strain TA100 (reverse gene mutation) and mouse hepatocytes (induction of UDS). The results implicate inhibition of CYP2E1 in this effect, since NDMA is activated to reactive products predominantly by this enzyme (30) . The inhibitory effects of sulforaphane in Salmonella were not seen with sodium azide, a genotoxicant that does not require metabolic activation, supporting a critical involvement of metabolism. The sulforaphane concentrations able to give statistically significant inhibition of bacterial mutagenesis and UDS induced by NDMA were as low as 0.8 \iM and 6 nM respectively. The AT, value for inhibition of p-nitrophenol hydroxylase was 37 uM. In comparison, the concentration at which sulforaphane caused marked induction, as evidenced by the doubling of transcription of genes linked to the mouse liver glutathione S-transferase Ya enhancer element transfected into Hep G2 human hepatoma cells, was near 0.5 JJ.M (31) . Sulforaphane has been extracted from broccoli and other plants (0.8 (imol sulforaphane/g fresh SAGA broccoli) (6), but there are no data available about the dose achieved in humans after vegetable consumption.
In preliminary studies we have now shown that sulforaphane also inhibits the CYP1A family (ethoxyresorufin O-deethylase) (unpublished data). The mechanism of this inhibition and potential effects on other CYP isoenzymes require further attention. The possibility that sulforaphane might also induce certain cytochrome P450 isoenzymes should also be investigated, although it appears to be a monofunctional inducer and unlikely to elevate cytochrome P450 (6, 32) . The forms of glutathione S-transferase induced by sulforaphane require characterization, since, for example, the inducible murine glutathione S-transferase YaYa has low activity towards many model substrates (33) .
Overall, the findings presented here suggest, for the first time, that sulforaphane is unlikely to be mutagenic and that it may afford protection against carcinogens which are substrates for CYP2E1 and glutathione S-transferase or quinone reductase via a dual mechanism. The effects on CYP2E1 are also likely to be relevant to humans, since there is a high conservation of catalytic and regulatory specificity between rodent and human forms (34) .
